Trials / Completed
CompletedNCT02902900
An Efficacy Study of Pomalidomide in Patient With Multiple Myeloma in Routine Clinical Practice
Observational Cohort Study Evaluating the Use and Efficacy of Pomalidomide in Patients With Multiple Myeloma in Routine Clinical Practice
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,504 (actual)
- Sponsor
- Celgene · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study, a national, multicenter, observational, ambispective, non-interventional study, will be conducted in French hospitals prescribing pomalidomide and already participating in the ongoing Imnovid registry. This study will add to the registry. Indeed, pomalidomide-prescribing physicians and pharmacists dispensing pomalidomide have to enter into the Imnovid registry all patients who have been prescribed this drug since the date on which it was marketed regardless of the initiation date of pomalidomide or the indication for which it was prescribed.
Conditions
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2022-05-31
- Completion
- 2022-05-31
- First posted
- 2016-09-16
- Last updated
- 2022-06-27
Locations
126 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02902900. Inclusion in this directory is not an endorsement.